| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.6M | -1.8% |
| R&D Expense | $240.8M | -24.7% |
| SG&A Expense | $136.9M | -34.8% |
| Operating Income | -$287.1M | +51.4% |
| Pre-tax Income | -$266.5M | +52.6% |
| Income Tax | $117K | -54.7% |
| Net Income | -$266.6M | +67.5% |
| EPS (Basic) | -$3.39 | +71.5% |
| EPS (Diluted) | -$3.39 | +71.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $113.0M | -29.9% |
| Short-term Investments | $67.3M | -51.3% |
| Current Assets | $199.5M | -40.7% |
| Total Assets | $554.9M | -6.5% |
| Current Liabilities | $128.2M | -16.2% |
| Total Liabilities | $358.6M | +63.3% |
| Stockholders' Equity | $196.3M | -47.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$353.0M | +44.5% |
| Capital Expenditures | $8.2M | -43.4% |
| Investing Cash Flow | $250.5M | -55.5% |
| Financing Cash Flow | $54.3M | +157.7% |
| Free Cash Flow | -$361.2M | +44.4% |